Brigham and Women's Faulkner Hospital is a 171-bed, non-profit community teaching hospital located in Boston, Massachusetts. Founded in 1900, it is located in the neighborhood of Jamaica Plain across the street from the Arnold Arboretum and just 3.4 miles from Longwood Medical and Academic Area.

There are 171 beds in Brigham and Women's Faulkner Hospital.

During the past decade, Brigham and Women's Faulkner Hospital conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 11 clinical trials were completed, i.e. on average, 44% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 6 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Brigham and Women's Faulkner Hospital" #1 sponsor was "Brigham and Women's Hospital" with 20 trials, followed by "Dana-Farber Cancer Institute" with 7 trials sponsored, "AirXpanders, Inc." with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored and "ETOP IBCSG Partners Foundation" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Brigham and Women's Faulkner Hospital" #1 collaborator was "Brigham and Women's Hospital" with 8 trials as a collaborator, "Beth Israel Deaconess Medical Center" with 7 trials as a collaborator, "Massachusetts General Hospital" with 6 trials as a collaborator, "Biofourmis Inc." with 3 trials as a collaborator and "Lowell General Hospital" with 3 trials as a collaborator. Other collaborators include 46 different institutions and companies that were collaborators in the rest 49 trials.

According to Clinical.Site data, the most researched conditions in "Brigham and Women's Faulkner Hospital" are "Breast Cancer" (9 trials), "Heart Failure" (8 trials), "Anticoagulants; Increased" (6 trials), "Asthma" (6 trials) and "Atrial Fibrillation Rapid" (6 trials). Many other conditions were trialed in "Brigham and Women's Faulkner Hospital" in a lesser frequency.

Most popular intervention types in "Brigham and Women's Faulkner Hospital" are "Drug" (14 trials), "Other" (14 trials), "Device" (8 trials), "Behavioral" (5 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (2 trials), "Home hospitalization" (2 trials), "AeroForm Tissue Expander" (1 trials), "AeroForm Tissue Expansion" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Brigham and Women's Faulkner Hospital" are 25 trials for "All" genders, 14 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 11 active trials in "Brigham and Women's Faulkner Hospital". 1 are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 23 completed trials in Brigham and Women's Faulkner Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Brigham and Women's Faulkner Hospital, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 18 trials that are defined as “Not Applicable".